CDTX vs K · rev $1.3M vs P/E 23, $29.03B cap
Cidara Therapeutics Inc (CDTX) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Kellanova (K) is a packaged foods company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
K does not have a complete income-statement cache yet.
CDTX currently screens at market cap $6.96B. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the CDTX and K stock pages for the full models.
Not investment advice.